Biolase (BIOL) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
BIOLASE Reports 2018 First Quarter Results
May 2, 2018 4:05 PM EDTIRVINE, Calif., May 2, 2018 /PRNewswire/ --Â BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for its first quarter ended March 31, 2018.
Net revenue for the first quarter of 2018 was $10.0 million, an 8% decrease from the first quarter of 2017; however, BIOLASE continued to make progress in several key areas. The Company continued its strategy of increasing its focus on obtaining new customers, which resulted in new customers in direct markets buying more than 60% of the all-tissue laser systems sold during the first quarter of 2018.... More



